20516 results for «»

Filter By

20516 results

Treatment effects of Interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest: the IMICA Trial

21 Sep 2021

The IMICA trial explored the effect of a single 1-hour infusion of Tocilizumab, initiated in patients as early as feasible in their hospital admission, post-cardiac arrest, and sought to investigate whether this would reduce the systemic inflammatory response.

Paul Hill

Reviewer

Paul Hill
Kalpa De Silva

Reviewer

Kalpa De Silva
Treatment effects of Interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest: the IMICA Trial

Paul Hill

London, United Kingdom

Paul Hill

MiniBAV through distal radial only

21 Sep 2021

From a clean puncture to a safe valvulotomy, a step by step video tour through performing distal radial MiniBAV – a novel technique.

Alexandru Achim

Author

Alexandru Achim
MiniBAV through distal radial only

Optimizing TAVI Procedures: Is Cusp Overlap Standard of Care?

23 Sep 2021 – From PCR Tokyo Valves 2021

Based on the results of the Optimize PRO and OCEAN-TAVI studies, Yohei Ohno and Yusuke Watanabe explain the key principles of the cusp overlap technique, a novel technique to potentially reduce new onset conduction disturbance. The objectives of the cusp overlap technique being to Determine, Assess, Reduce, and...

Optimizing TAVI Procedures: Is Cusp Overlap Standard of Care?

Planning for the Future: Lifetime Management Considerations for TAVI Patients

23 Sep 2021 – From PCR Tokyo Valves 2021

By establishing a constant parallel between the situation in the United States and that in Japan, based on data collected daily, Jeffrey Popma and Shinichi Shirai provide current insights into the use of the soft expanding supra-annular evolution platform. In particular, they address the question of which patient...

Planning for the Future: Lifetime Management Considerations for TAVI Patients

Influenza Vaccination after Myocardial Infarction: IAMI

24 Sep 2021

The objective of the IAMI1 trial was to determine whether early influenza vaccination reduces the risk of cardiovascular events in patients admitted with an acute-MI or high-risk stable coronary artery disease in an adequately powered randomized control trial setting.

Christopher Johnston

Reviewer

Christopher Johnston
Kalpa De Silva

Reviewer

Kalpa De Silva
Influenza Vaccination after Myocardial Infarction: IAMI

Christopher Johnston

Newcastle

Christopher Johnston

Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

24 Sep 2021

Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Patrick M. Looser

Reviewer

Patrick M. Looser
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

Patrick M. Looser

United States of America

Patrick M. Looser

World Heart Day 2021 - Pandemic and heart diseases: lessons learnt for the future

27 Sep 2021

Giulio Stefanini and Emanuele Barbato take the opportunity of World Heart Day to review the impact of the Covid-19 pandemic on cardiovascular care at a time when the pandemic has highlighted the gaps between different health systems.

Giulio Stefanini

Author

Giulio Stefanini
Prof. Emanuele BARBATO

Author

Emanuele Barbato
World Heart Day 2021 - Pandemic and heart diseases: lessons learnt for the future

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform

Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology

27 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...

Introducing Navitor:

Contemporary procedural practice for TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Contemporary procedural practice for TAVI

Case-based challenging heart team decisions in combined structural heart diseases

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this case-based session on combined structural heart diseases to discover what is the heart team approach for complex structure heart diseases, as well as how to manage a patient with multiple diseases.

Case-based challenging heart team decisions in combined structural heart diseases

Valve-in-valve TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.

Valve-in-valve TAVI

Edge-to-edge mitral repair

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.

Edge-to-edge mitral repair

TAVI and coronary artery disease

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

TAVI and coronary artery disease

Update on new guidelines for management of patients with valvular heart disease

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session on the management of patients with valvular heart disease to learn about the new guidelines, and discover how to apply them to your daily practice.

Update on new guidelines for management of patients with valvular heart disease

Bicuspid aortic valves: where do we stand?

26 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.

Bicuspid aortic valves: where do we stand?
Didn’t find what you were looking for?